Aligos Therapeutics Inc
ALGS
$5.34+0.56%
End of day · as of Oct 10, 2026, 8:00 PM ET
Mkt cap
$44.09M
EV/Sales
11.8
P/E ratio
N/A
FY2025 Revenue
$2.19M
EPS (TTM)
$-7.71
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-1106.72%
Beta
2.69
Div yield
N/A
Sector
Healthcare
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Latest reported ALGS revenue for 2025-12-31 was $2.2M. Net income was -$24.2M. Revenue was down 39.5% from 2024-12-31 to 2025-12-31. ALGS currently screens at market cap $44.1M.
Use this ALGS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ALGS income, balance, and cash tables.
Aligos Therapeutics Inc (ALGS) is a biotechnology company in the Healthcare sector.
Latest cached Aligos Therapeutics Inc (ALGS) revenue for Dec 31, 2025 was $2.2M. Net income was -$24.2M. Statements: https://lician.com/financials/algs
Aligos Therapeutics Inc (ALGS) market capitalization is $44.1M on the latest cached snapshot.
Aligos Therapeutics Inc (ALGS) cached previous close $5.31; day range $5.27 – $5.44; volume 8,909. Session quote: https://lician.com/quote/algs
Aligos Therapeutics Inc (ALGS) latest cached earnings event is "ALGS earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ALGS filing is 8-K · Sep 15, 2026. Filings: https://lician.com/sec/algs